Boston Financial & Equity Corporation announced the closing of a $250,000 equipment lease line with a drug discovery company based in Pittsburgh, PA.

The company, founded in 2010 has generated revenue from big pharmaceuticals such as Pfizer, Merck and Amgen, but is still a ways away from profitability. The company brings a newly created way to bring targeted biosensors to the cellular biology research community. While the company does not expect to be profitable until 2017, they have raised $1,000,000 to date.

With 10-12 months of cash at their current burn rate, and fungible assets with strong resale values, Boston Financial provided the company with a 36 month master equipment lease.